1.
Vohra SR, Ravichandran S, Foard D, Martinez-Naharro A, Venneri L, Fontana M, Whelan CJ, Hawkins PN, Gillmore J, Lachmann HJ, Mahmood S, Wechalekar AD. A retrospective study of isatuximab-pomalidomidedexamethasone in relapsed/refractory systemic AL amyloidosis. Haematologica 2025;110(12):3109-3113; https://doi.org/10.3324/haematol.2025.287664.